Teleflex Investor Presentation

9 High Growth Portfolio - Early Penetration of Global Addressable Market Opportunity High Growth Portfolio ~$720M in 2022 Revenue 5% Penetration of Global Addressable Market1 The UroLift® System: $12B+ Hemostatic Products: ~$600M Arrow® EZ-IO® Intraosseous Vascular Access System: ~$500M PICC Portfolio: $400M-$500M Arrow OnControl® Powered Bone Access System: ~$200M MANTAⓇ Vascular Closure Device: $200M-$300M Titan SGS® Stapler: ~$250M 1. Calculated using 2022 revenue as a percentage of total global addressable market for the High Growth portfolio of products. Titan SGS Stapler added to portfolio through the acquisition of Standard Bariatrics in 2022. Teleflex®

View entire presentation